Open access · CC-BY
via OpenAlex
Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations
Sarah Ashiqueali, Augusto Schneider, Xiang Zhu, Ewelina Juszczyk, Mishfak A. M. Mansoor, Yun Xia Zhu, Yimin Fang, Bianka M. Zanini, Driele Neske Garcia, Natalie Hayslip, David Medina, Samuel McFadden, Robert Stockwell, Rong Yuan, Andrzej Bartke
Aging Cell · 2024 · ▲ 5 citations
Epigenetic alterations
Deregulated nutrient-sensing
Caloric restriction
Rapamycin / mTOR inhibition
Metformin
Mouse
Abstract
Recent studies have demonstrated the remarkable potential of early life intervention strategies at influencing the course of postnatal development, thereby offering exciting possibilities for enhancing longevity and improving overall health. Metformin (MF), an FDA-approved medication for type II diabetes mellitus, has recently gained attention for its promising anti-aging properties, acting as a calorie restriction mimetic, and delaying precocious puberty. Additionally, trodusquemine (MSI-1436), an investigational drug, has been shown to combat obesity and metabolic disorders by inhibiting the enzyme protein tyrosine phosphatase 1b (Ptp1b), consequently reducing hepatic lipogenesis and counteracting insulin and leptin resistance. In this study, we aimed to further explore the effects of these compounds on young, developing mice to uncover biomolecular signatures that are central to liver metabolic processes. We found that MSI-1436 more potently alters mRNA and miRNA expression in the liver compared with MF, with bioinformatic analysis suggesting that cohorts of differentially expressed miRNAs inhibit the action of phosphoinositide 3-kinase (Pi3k), protein kinase B (Akt), and mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (Mtor) to regulate the downstream processes of de novo lipogenesis, fatty acid oxidation, very-low-density lipoprotein transport, and cholesterol biosynthesis and efflux. In summary, our study demonstrates that administering these compounds during the postnatal window metabolically reprograms the liver through induction of potent epigenetic changes in the transcriptome, potentially forestalling the onset of age-related diseases and enhancing longevity. Future studies are necessary to determine the impacts on lifespan and overall quality of life.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.14227
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Ashiqueali, S., Schneider, A., Zhu, X., Juszczyk, E., Mansoor, M.A.M., Zhu, Y.X., Fang, Y., Zanini, B.M., Garcia, D.N., Hayslip, N., Medina, D., McFadden, S., Stockwell, R., Yuan, R., Bartke, A., ZASLOFF, M.A., Siddiqi, S.A., & Masternak, M.M. (2024). Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations. <em>Aging Cell</em>. https://doi.org/10.1111/acel.14227
Vancouver
Ashiqueali S, Schneider A, Zhu X, Juszczyk E, Mansoor MAM, Zhu YX, et al. Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations. Aging Cell. 2024. doi:10.1111/acel.14227.
BibTeX
@article{sarah2024Earlyl,
title = {Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations},
author = {Sarah Ashiqueali and Augusto Schneider and Xiang Zhu and Ewelina Juszczyk and Mishfak A. M. Mansoor and Yun Xia Zhu and Yimin Fang and Bianka M. Zanini and Driele Neske Garcia and Natalie Hayslip and David Medina and Samuel McFadden and Robert Stockwell and Rong Yuan and Andrzej Bartke and MICHAEL A. ZASLOFF and Shadab A. Siddiqi and Michał M. Masternak},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14227},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2015
Open access · CC-BY
Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth Retardation
PLoS ONE 2011
Open access · CC-BY
Lifespan-Extending Effects of Royal Jelly and Its Related Substances on the Nematode Caenorhabditis elegans
Ageing Research Reviews 2025
Open access · CC-BY
Emerging uncertainty on the anti-aging potential of metformin
Frontiers in Nutrition 2026
Open access · CC-BY
Nutritional redox reprogramming in cardiometabolic diseases: alpha-lipoic acid, urolithin A, and ergothioneine as modulators of the ferroptosis–mitophagy axis and mitochondrial metabolic remodeling
Biomedicines 2021
Open access · CC-BY
Immunomodulatory Role of Urolithin A on Metabolic Diseases
International journal of molecular sciences 2025
Open access · OA